342 related articles for article (PubMed ID: 31498923)
1. Determinants of glycaemic outcome in the current practice of care for young people up to 21 years old with type 1 diabetes under real-life conditions.
Kordonouri O; Lange K; Biester T; Datz N; Kapitzke K; von dem Berge T; Weiskorn J; Danne T
Diabet Med; 2020 May; 37(5):797-804. PubMed ID: 31498923
[TBL] [Abstract][Full Text] [Related]
2. Continuous subcutaneous insulin infusion versus multiple daily injections in children and young people at diagnosis of type 1 diabetes: the SCIPI RCT.
Blair J; McKay A; Ridyard C; Thornborough K; Bedson E; Peak M; Didi M; Annan F; Gregory JW; Hughes D; Gamble C
Health Technol Assess; 2018 Aug; 22(42):1-112. PubMed ID: 30109847
[TBL] [Abstract][Full Text] [Related]
3. Marked improvements in glycaemic outcomes following insulin pump therapy initiation in people with type 1 diabetes: a nationwide observational study in Scotland.
Jeyam A; Gibb FW; McKnight JA; Kennon B; O'Reilly JE; Caparrotta TM; Höhn A; McGurnaghan SJ; Blackbourn LAK; Hatam S; McCrimmon RJ; Leese G; Lindsay RS; Petrie J; Chalmers J; Philip S; Wild SH; Sattar N; McKeigue PM; Colhoun HM;
Diabetologia; 2021 Jun; 64(6):1320-1331. PubMed ID: 33686483
[TBL] [Abstract][Full Text] [Related]
4. Insulin pump use in pregnancy is associated with lower HbA1c without increasing the rate of severe hypoglycaemia or diabetic ketoacidosis in women with type 1 diabetes.
Kallas-Koeman MM; Kong JM; Klinke JA; Butalia S; Lodha AK; Lim KI; Duan QM; Donovan LE
Diabetologia; 2014 Apr; 57(4):681-9. PubMed ID: 24434960
[TBL] [Abstract][Full Text] [Related]
5. Route to improving Type 1 diabetes mellitus glycaemic outcomes: real-world evidence taken from the National Diabetes Audit.
Heald AH; Livingston M; Fryer A; Moreno GYC; Malipatil N; Gadsby R; Ollier W; Lunt M; Stedman M; Young RJ
Diabet Med; 2018 Jan; 35(1):63-71. PubMed ID: 29120503
[TBL] [Abstract][Full Text] [Related]
6. Continuous subcutaneous insulin infusion versus multiple daily injection regimens in children and young people at diagnosis of type 1 diabetes: pragmatic randomised controlled trial and economic evaluation.
Blair JC; McKay A; Ridyard C; Thornborough K; Bedson E; Peak M; Didi M; Annan F; Gregory JW; Hughes DA; Gamble C;
BMJ; 2019 Apr; 365():l1226. PubMed ID: 30944112
[TBL] [Abstract][Full Text] [Related]
7. Glycaemic outcomes in Australasian children and adults with type 1 diabetes: failure to meet targets across the age spectrum.
Holmes-Walker DJ; Abraham MB; Chee M; Jones TW;
Intern Med J; 2023 Jan; 53(1):61-67. PubMed ID: 34142758
[TBL] [Abstract][Full Text] [Related]
8. The Transatlantic HbA
Hermann JM; Miller KM; Hofer SE; Clements MA; Karges W; Foster NC; Fröhlich-Reiterer E; Rickels MR; Rosenbauer J; DeSalvo DJ; Holl RW; Maahs DM;
Diabet Med; 2020 May; 37(5):848-855. PubMed ID: 31557351
[TBL] [Abstract][Full Text] [Related]
9. Characteristics of adult- compared to childhood-onset type 1 diabetes.
Casu A; Kanapka LG; Foster NC; Hirsch IB; Laffel LM; Shah VN; DeSalvo DJ; Lyons SK; Vendrame F; Aleppo G; Mastrandrea LD; Pratley RE; Rickels MR; Peters AL;
Diabet Med; 2020 Dec; 37(12):2109-2115. PubMed ID: 32353892
[TBL] [Abstract][Full Text] [Related]
10. A cluster randomised trial, cost-effectiveness analysis and psychosocial evaluation of insulin pump therapy compared with multiple injections during flexible intensive insulin therapy for type 1 diabetes: the REPOSE Trial.
Heller S; White D; Lee E; Lawton J; Pollard D; Waugh N; Amiel S; Barnard K; Beckwith A; Brennan A; Campbell M; Cooper C; Dimairo M; Dixon S; Elliott J; Evans M; Green F; Hackney G; Hammond P; Hallowell N; Jaap A; Kennon B; Kirkham J; Lindsay R; Mansell P; Papaioannou D; Rankin D; Royle P; Smithson WH; Taylor C
Health Technol Assess; 2017 Apr; 21(20):1-278. PubMed ID: 28440211
[TBL] [Abstract][Full Text] [Related]
11. Real-world outcomes with different technology modalities in type 1 diabetes.
Beato-Víbora PI; Gallego-Gamero F; Ambrojo-López A
Nutr Metab Cardiovasc Dis; 2021 Jun; 31(6):1845-1850. PubMed ID: 33838993
[TBL] [Abstract][Full Text] [Related]
12. Metabolic control and complications in Italian people with diabetes treated with continuous subcutaneous insulin infusion.
Lepore G; Bonfanti R; Bozzetto L; Di Blasi V; Girelli A; Grassi G; Iafusco D; Laviola L; Rabbone I; Schiaffini R; Bruttomesso D;
Nutr Metab Cardiovasc Dis; 2018 Apr; 28(4):335-342. PubMed ID: 29428572
[TBL] [Abstract][Full Text] [Related]
13. Predictors of glycaemic control in patients with Type 1 diabetes commencing continuous subcutaneous insulin infusion therapy.
Shalitin S; Gil M; Nimri R; de Vries L; Gavan MY; Phillip M
Diabet Med; 2010 Mar; 27(3):339-47. PubMed ID: 20536498
[TBL] [Abstract][Full Text] [Related]
14. Paediatric estimated average glucose in children with Type 1 diabetes.
O'Riordan SM; Danne T; Hanas R; Peters CJ; Hindmarsh P
Diabet Med; 2014 Jan; 31(1):36-9. PubMed ID: 23869869
[TBL] [Abstract][Full Text] [Related]
15. Improved metabolic control in pediatric patients with type 1 diabetes: a nationwide prospective 12-year time trends analysis.
Dovc K; Telic SS; Lusa L; Bratanic N; Zerjav-Tansek M; Kotnik P; Stefanija MA; Battelino T; Bratina N
Diabetes Technol Ther; 2014 Jan; 16(1):33-40. PubMed ID: 24131373
[TBL] [Abstract][Full Text] [Related]
16. Use of continuous glucose monitoring in patients with diabetes on peritoneal dialysis: poor correlation with HbA1c and high incidence of hypoglycaemia.
Oei E; Samad N; Visser A; Chowdhury TA; Fan SL
Diabet Med; 2016 Sep; 33(9):e17-20. PubMed ID: 26470840
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of liraglutide for overweight adult patients with type 1 diabetes and insufficient glycaemic control (Lira-1): a randomised, double-blind, placebo-controlled trial.
Dejgaard TF; Frandsen CS; Hansen TS; Almdal T; Urhammer S; Pedersen-Bjergaard U; Jensen T; Jensen AK; Holst JJ; Tarnow L; Knop FK; Madsbad S; Andersen HU
Lancet Diabetes Endocrinol; 2016 Mar; 4(3):221-232. PubMed ID: 26656289
[TBL] [Abstract][Full Text] [Related]
18. Glycaemic control of Type 1 diabetes in clinical practice early in the 21st century: an international comparison.
McKnight JA; Wild SH; Lamb MJ; Cooper MN; Jones TW; Davis EA; Hofer S; Fritsch M; Schober E; Svensson J; Almdal T; Young R; Warner JT; Delemer B; Souchon PF; Holl RW; Karges W; Kieninger DM; Tigas S; Bargiota A; Sampanis C; Cherubini V; Gesuita R; Strele I; Pildava S; Coppell KJ; Magee G; Cooper JG; Dinneen SF; Eeg-Olofsson K; Svensson AM; Gudbjornsdottir S; Veeze H; Aanstoot HJ; Khalangot M; Tamborlane WV; Miller KM
Diabet Med; 2015 Aug; 32(8):1036-50. PubMed ID: 25510978
[TBL] [Abstract][Full Text] [Related]
19. Diabetes technology and treatments in the paediatric age group.
Shalitin S; Peter Chase H
Int J Clin Pract Suppl; 2011 Feb; (170):76-82. PubMed ID: 21323816
[TBL] [Abstract][Full Text] [Related]
20. Continuous glucose monitoring versus blood glucose monitoring for risk of severe hypoglycaemia and diabetic ketoacidosis in children, adolescents, and young adults with type 1 diabetes: a population-based study.
Karges B; Tittel SR; Bey A; Freiberg C; Klinkert C; Kordonouri O; Thiele-Schmitz S; Schröder C; Steigleder-Schweiger C; Holl RW
Lancet Diabetes Endocrinol; 2023 May; 11(5):314-323. PubMed ID: 37004710
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
